- Home
- TVTX vs ATEC Comparison
TVTX vs ATEC Comparison
Compare TVTX & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- ATEC
- Stock Information
- Founded
- TVTX 2008
- ATEC 1990
- Country
- TVTX United States
- ATEC United States
- Employees
- TVTX N/A
- ATEC N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- ATEC Medical/Dental Instruments
- Sector
- TVTX Health Care
- ATEC Health Care
- Exchange
- TVTX Nasdaq
- ATEC Nasdaq
- Market Cap
- TVTX 1.5B
- ATEC 1.3B
- IPO Year
- TVTX N/A
- ATEC 2006
- Fundamental
- Price
- TVTX $18.37
- ATEC $11.57
- Analyst Decision
- TVTX Buy
- ATEC Strong Buy
- Analyst Count
- TVTX 12
- ATEC 11
- Target Price
- TVTX $24.58
- ATEC $18.09
- AVG Volume (30 Days)
- TVTX 1.2M
- ATEC 1.6M
- Earning Date
- TVTX 02-13-2025
- ATEC 02-26-2025
- Dividend Yield
- TVTX N/A
- ATEC N/A
- EPS Growth
- TVTX N/A
- ATEC N/A
- EPS
- TVTX N/A
- ATEC N/A
- Revenue
- TVTX $203,447,000.00
- ATEC $572,739,000.00
- Revenue This Year
- TVTX $62.38
- ATEC $27.98
- Revenue Next Year
- TVTX $57.65
- ATEC $20.55
- P/E Ratio
- TVTX N/A
- ATEC N/A
- Revenue Growth
- TVTX 57.08
- ATEC 27.21
- 52 Week Low
- TVTX $5.12
- ATEC $4.88
- 52 Week High
- TVTX $20.33
- ATEC $17.34
- Technical
- Relative Strength Index (RSI)
- TVTX 52.05
- ATEC 77.15
- Support Level
- TVTX $16.80
- ATEC $9.09
- Resistance Level
- TVTX $18.76
- ATEC $11.51
- Average True Range (ATR)
- TVTX 0.90
- ATEC 0.55
- MACD
- TVTX 0.02
- ATEC 0.23
- Stochastic Oscillator
- TVTX 61.57
- ATEC 98.21
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.
About ATEC Alphatec Holdings Inc.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.